Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.StemCells has entered into research collaboration with the Oregon Health & Science University Casey Eye Institute to evaluate the company's proprietary HuCNS-SC product candidate as a potential treatment for retinal degeneration, a leading cause of blindness.
Subscribe to our email newsletter
Under the collaboration, the parties will evaluate engraftment and function of StemCells’s HuCNS-SC cells in the same rat model preparatory to planned clinical trials. The research, which is expected to be concluded by the end of 2008, will be conducted at OHSU.
Stephen Huhn, vice president and head of the CNS Program of StemCells, said: “This collaboration advances our mission to develop novel treatments for diseases of all three elements of the central nervous system – the brain, the spinal cord and the eye.”